WO2008003925A3 - Protéine du complément - Google Patents

Protéine du complément Download PDF

Info

Publication number
WO2008003925A3
WO2008003925A3 PCT/GB2007/002334 GB2007002334W WO2008003925A3 WO 2008003925 A3 WO2008003925 A3 WO 2008003925A3 GB 2007002334 W GB2007002334 W GB 2007002334W WO 2008003925 A3 WO2008003925 A3 WO 2008003925A3
Authority
WO
WIPO (PCT)
Prior art keywords
protein
complement protein
complement
insp191
termed
Prior art date
Application number
PCT/GB2007/002334
Other languages
English (en)
Other versions
WO2008003925A2 (fr
Inventor
Richard Joseph Fagan
Stephen Noel Fitzgerald
Original Assignee
Ares Trading Sa
Richard Joseph Fagan
Stephen Noel Fitzgerald
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ares Trading Sa, Richard Joseph Fagan, Stephen Noel Fitzgerald filed Critical Ares Trading Sa
Publication of WO2008003925A2 publication Critical patent/WO2008003925A2/fr
Publication of WO2008003925A3 publication Critical patent/WO2008003925A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/472—Complement proteins, e.g. anaphylatoxin, C3a, C5a

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Cette invention concerne une nouvelle protéine, appelée INSP191, identifiée ici comme protéine sécrétée, en particulier, comme protéine du complément; l'invention concerne aussi l'utilisation de cette protéine et de la séquence d'acide nucléique provenant du gène codant dans le diagnostic, la prévention et le traitement d'une maladie.
PCT/GB2007/002334 2006-07-06 2007-06-25 Protéine du complément WO2008003925A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0613471.2 2006-07-06
GB0613471A GB0613471D0 (en) 2006-07-06 2006-07-06 Protein

Publications (2)

Publication Number Publication Date
WO2008003925A2 WO2008003925A2 (fr) 2008-01-10
WO2008003925A3 true WO2008003925A3 (fr) 2008-02-28

Family

ID=36926595

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2007/002334 WO2008003925A2 (fr) 2006-07-06 2007-06-25 Protéine du complément

Country Status (2)

Country Link
GB (1) GB0613471D0 (fr)
WO (1) WO2008003925A2 (fr)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001081578A2 (fr) * 2000-04-26 2001-11-01 Curagen Corporation Nouvelles proteines et acides nucleiques codant ces dernieres
WO2002102321A2 (fr) * 2001-06-18 2002-12-27 Curagen Corporation Proteines et acides nucleiques les codant
US20040029220A1 (en) * 2000-04-26 2004-02-12 Vernet Corine A.M. Novel proteins and nucleic acids encoding same
WO2005049806A2 (fr) * 2003-03-14 2005-06-02 Nuvelo, Inc. Nouveaux acides nucleiques et polypeptides

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001081578A2 (fr) * 2000-04-26 2001-11-01 Curagen Corporation Nouvelles proteines et acides nucleiques codant ces dernieres
US20040029220A1 (en) * 2000-04-26 2004-02-12 Vernet Corine A.M. Novel proteins and nucleic acids encoding same
WO2002102321A2 (fr) * 2001-06-18 2002-12-27 Curagen Corporation Proteines et acides nucleiques les codant
WO2005049806A2 (fr) * 2003-03-14 2005-06-02 Nuvelo, Inc. Nouveaux acides nucleiques et polypeptides

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
SAHU A ET AL: "Structure and biology of complement protein C3, a connecting link between innate and acquired immunity", IMMUNOLOGICAL REVIEWS, MUNKSGAARD, vol. 180, April 2001 (2001-04-01), pages 35 - 48, XP002962792, ISSN: 0105-2896 *

Also Published As

Publication number Publication date
GB0613471D0 (en) 2006-08-16
WO2008003925A2 (fr) 2008-01-10

Similar Documents

Publication Publication Date Title
WO2007095316A3 (fr) Compositions et procédés pour formulations à base d'oligonucléotides
WO2008036765A3 (fr) Micro arn exprimés par différenciation dans les maladies du pancréas, et leur utilisation
WO2007117438A3 (fr) Méthodes de production d'une protéine fonctionnelle à partir d'un adn présentant une mutation non-sens et traitement des troubles associés
WO2006128041A3 (fr) Compositions et procedes destines a traiter ou a prevenir un neoplasme chimiomoresistant
WO2008088524A3 (fr) Protéine r-spondine 1 à carence en domaines de thrombospondine utilisee en tant que facteur de prolifération épithéliale du tractus gastro-intestinal
IL169367A0 (en) Defensin proteins
WO2008095622A3 (fr) Luciférase secrétée mluc7 et son utilisation
WO2006046073A3 (fr) Proteine du type c1q
WO2008015380A3 (fr) Protéine membranaire intégrale
WO2006043060A3 (fr) Proteine contenant le domaine mam
WO2006016172A3 (fr) Glycoproteine de surface
IL169256A0 (en) Metalloprotease proteins
WO2007049065A3 (fr) Proteine contenant des domaines vwfa, collagene et kunitz
WO2008003925A3 (fr) Protéine du complément
WO2008001045A8 (fr) Membres de la famille de protéines connue sous le nom de famille des glycosides hydrolases 31
WO2007068913A3 (fr) Protéines contenant le domaine SRCR-B
WO2004009633A8 (fr) Recepteur de serotonine
WO2006051333A3 (fr) Proteines contenant des motifs repetes riches en leucine (lrr)
WO2007049062A3 (fr) Protéines contenant des domaines vwfa
WO2004101618A3 (fr) Proteines associees au recepteur de progestine yol002c-cgi-45
WO2008012505A8 (fr) Glycoprotéine membranaire ancrée par gpi
WO2008033374A3 (fr) Compositions de ocl-2a3 et utilisations de celles-ci
WO2004081170A3 (fr) Proteine de type recepteur de la progestine
WO2003066844A3 (fr) Proteine p450 cytochrome
WO2005080425A3 (fr) Proteine contenant une sequence nucleotidique repetee riche en leucine

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07733329

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: RU

122 Ep: pct application non-entry in european phase

Ref document number: 07733329

Country of ref document: EP

Kind code of ref document: A2